Related Experiment Video
Updated: May 31, 2026
10:12
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Alzheimer's disease: cholesterol a menace?
Anila Mathew1, Yasuhiko Yoshida, Toru Maekawa
1Bio-Nano Electronics Research Centre, Graduate School of Interdisciplinary New Science, Toyo University, Kujirai, Kawagoe-shi, Saitama, Japan.
Brain Research Bulletin
|July 12, 2011
Summary
Alzheimer's disease (AD) involves memory loss and cognitive decline. This review explores how cholesterol contributes to AD pathogenesis, particularly its link to amyloid plaque generation.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Alzheimer's disease (AD) is a leading neurodegenerative disorder causing cognitive and memory decline.
- AD is multifactorial, influenced by genetics and diet, leading to significant personal and societal impact.
Purpose of the Study:
- To review the role of cholesterol in the etiology of Alzheimer's disease.
- To examine the connection between cholesterol and amyloid plaque formation in AD pathogenesis.
Main Methods:
- Literature review of studies investigating cholesterol's role in Alzheimer's disease.
- Analysis of research on cholesterol's association with amyloid plaque generation.
Main Results:
- Cholesterol is closely implicated in the generation of amyloid plaques, a key feature of AD.
- While some studies present conflicting data, most evidence indicates a positive association between cholesterol levels and AD.
Conclusions:
- Cholesterol plays a significant role in Alzheimer's disease pathogenesis, particularly concerning amyloid plaques.
- Further research is needed to clarify the complex relationship between cholesterol and AD, despite strong indications of a positive link.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...